It sounds simple. Private equity firms want portfolio companies to have strong, fairly priced insurance — ideally leveraging sponsor buying power. Yet, the D&O market has resisted standardized policy forms.

Amwins partnered with leading markets to create a tailored solution addressing the unique risks of portfolio companies, their leaders, and financial sponsors. Designed for transactions, high-growth sectors, and areas where traditional D&O falls short, the program covers acquisitions, regulatory scrutiny, and shareholder activity with flexibility and precision.

By combining market relationships with technical expertise, Amwins delivers coverage aligned to the strategic needs of sponsors and their portfolio companies.

Coverage Highlights:

• Affirmative, full limit coverage for anti-trust claims
• Coverage extends to regulatory investigations and pre-claim inquiries – may be subject to sublimit
• No acquisition threshold for mid-term acquisitions
• “Other insurance” section structured to respond as primary over sponsor/investor GPL policies
• Pre-set run-off options for up to six years with guaranteed pricing
• To deny claims for late reporting the carriers must show they were prejudiced by the late reporting

Defense

• Optional duty to defend provision
• Defense is on a reimbursement basis with the option to tender defense with 60 days of noticing the claim – when tendered, 100% defense cost allocation provided
• Affirmative coverage for defense costs for:
  • Breach of Contract claims in the D&O
  • Certain IP-related claims subject to sublimit

Exclusions

• Exclusions for Side A are limited to Conduct, Prior Notice, and Prior Litigation – closely resembling a typical Side A DIC policy
• Refined “Insured vs. Insured” exclusion to “Entity vs. Insured”
• No bump-up exclusion
• Numerous exclusions softened with “for” wording

Appetite/Target Clients

• Must have institutional/PE/VC backing including family office ownership and independent sponsors
• Broad industry class appetite